Navigation Links
Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited

TUALATIN, Ore., Jan. 26 /PRNewswire-FirstCall/ -- Waytronx, Inc. (OTC Bulletin Board: WYNX), a platform company dedicated to the acquisition, development, and commercialization of new, innovative technologies, today announced that it has reached an agreement with British-based Ingenion Design Ltd. ("Ingenion") to develop and build its second generation Gas Quality Inferential Measurement Device (GasPT2).

The GasPT2, designed by GL Industrial Services ("GL") and recently licensed worldwide and exclusively to Waytronx, is a low cost solution to measuring gas quality.  It can be connected to a natural gas system to provide a fast, accurate, close to real time measurement of the gas physical properties, such as thermal conductivity, speed of sound and carbon dioxide content.  From these measurements it infers an effective gas mixture comprising four components: methane, propane, nitrogen, and measured carbon dioxide and then uses ISO6976 to calculate the gas quality characteristics of calorific value (CV), Wobbe index (WI), relative density (RD), and compression factor (Z).

This new relationship between Ingenion and Waytronx allows for final development and manufacturing of the GasPT2 by the company that has been producing the original version of the device for several years.

"Developing a relationship with Ingenion was critical to our strategy of rapidly introducing this exciting technology into the natural gas market," explained Waytronx President & CEO, William Clough.  "Use of the well respected and internationally recognized services of an industry leading manufacturer like Ingenion, coupled with our previously announced relationship with GL, guarantees the acceptance of this technology into the rapidly growing natural gas market," Clough continued.

As manufacturer of the previous version of the GasPT, Ingenion has already produced the device for such industry leaders as BP Wytch Farm; BP Coryton; CTS; Niigata; Osaka Gas; Tokyo Gas; Yanmer Gas; Owens Corning Fiberglass; Corus; Perenco Bacton; British Gas Isle of Grain Facility; ExxonMobil South Hook Facility; GE; and others.

Ingenion is a fully certified ISO9001:2000 company, approved to manufacture electronic equipment for industrial, laboratory, telecommunications, and biomedical industries, including Intrinsically Safe equipment covered by the ATEX directive.  Ingenion offers an extensive range of solutions including hardware and software designs specifically for Hazardous Areas (ATEX certified product) such as those found in the natural gas industry.  Ingenion prides itself on producing high quality products for use in extreme environments as evidenced by its ATEX and ISO certifications.

Peter Dyke, Ingenion's Co-Founder and Managing Director stated, "We are quite excited to finalize our relationship with Waytronx.  We offer our customers a complete 'one-stop shop' turnkey solution, taking the initial concept through the design process, EMC testing, prototyping, and finally into production where we then turn out 'boxed' products ready to deliver."

"Our previous experience in manufacturing the original version of the GasPT device for GL, including BASEEFA certification, will enable us to avoid the pitfalls normally associated with 'new' technology in the natural gas industry," explained Dyke.

"Waytronx relationship with GL and Ingenion continues to demonstrate our commitment to partner with the 'best of breed,' world-class companies in order to acquire, develop, and commercialize leading edge technology designed to grow our business, while enhancing and increasing shareholder value.  The GasPT2 device is a cornerstone for our continued growth into 2010 and beyond," concluded Clough.

About Waytronx, Inc.

Waytronx, Inc. has pioneered and is developing innovative thermal management solutions capable of revolutionizing the semiconductor, solar and electronic packaging industries, among others, utilizing its patented WayCool™/WayFast™ hybrid mesh architecture.  In addition, through its acquisition of CUI in May 2008, Waytronx has developed the infrastructure, expertise, and platform necessary to acquire, develop, and commercialize new, innovative technologies.  Waytronx changed its name from OnScreen Technologies in December 2007. For more information, please visit  

About CUI, Inc.

CUI, Inc. is a solutions provider of electromechanical components and industrial controls for OEM manufacturing. Since its inception in 1989, CUI has been delivering quality products, extensive application solutions, and superior personal service.  CUI's solid customer commitment and honest corporate message are a hallmark in the industry.  CUI is a wholly-owned subsidiary of Waytronx, Inc. For more information, please visit

This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements.  The company may experience significant fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, our reliance on third-party manufacturers and suppliers, government agency budgetary and political constraints, new or increased competition, changes in market demand, and the performance or reliability of our products.  These factors and others could cause operating results to vary significantly from those in prior periods, and those projected in forward-looking statements.  Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in certain forms the company has filed with the Securities and Exchange Commission.

WayCool, WayFast, Waytronx and OnScreen are trademarks of Waytronx, Inc. Other names and brands are the property of their respective owners.

SOURCE Waytronx, Inc.



SOURCE Waytronx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
(Date:11/24/2015)... - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" ... , President and Chief Executive Officer of ProMetic, will be ... th Annual Healthcare Conference to be held at the ... st , at 8.50am (ET) and ProMetic,s management team ... presentation will be available live via a webcast accessible at ...
(Date:11/24/2015)... Nev. , Nov. 24, 2015  PDL BioPharma, Inc. ... P. McLaughlin , the company,s president and chief executive officer, ... Healthcare Conference next week in New York City ... occur on Tuesday, December 1, 2015 at 9:30 a.m. EST. ... Please connect to the website at least 15 minutes prior ...
(Date:11/24/2015)... Nov. 24, 2015 According to two new studies, ... This is something that many doctors, scientists, and public health ... remains: with fewer PSA tests being done, will there be ... Dr. David Samadi, "Despite the efforts made in ... the second leading cancer cause of death in men, killing ...
(Date:11/23/2015)... 2015 China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the second quarter and ... 2015. --> --> ... for the second quarter of fiscal 2016 increased by ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... the explosion of technology-enabled health and wellness, and the ... book, The Internet of Healthy Things ... or smartphones even existed, Dr. Kvedar, vice president, Connected ... health care delivery, moving care from the hospital or ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
Breaking Biology News(10 mins):